La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Glory Health Industry Bilan de santé

Santé financière contrôle des critères 3/6

Glory Health Industry possède un total de capitaux propres de CN¥13.8B et une dette totale de CN¥22.2B, ce qui porte son ratio d'endettement à 160.9%. Son actif total et son passif total sont CN¥56.4B et de CN¥42.6B.

Informations clés

160.9%

Ratio d'endettement

CN¥22.17b

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	CN¥152.22m
Fonds propres	CN¥13.79b
Total du passif	CN¥42.57b
Total des actifs	CN¥56.35b

Mises à jour récentes de la santé financière

Recent updates

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Jun 21

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

Oct 07

Health Check: How Prudently Does Glory Health Industry (HKG:2329) Use Debt?

Jun 21

A Look At The Fair Value Of Glory Health Industry Limited (HKG:2329)

May 13

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

Oct 04

We Think Guorui Properties (HKG:2329) Is Taking Some Risk With Its Debt

Apr 20

Here's Why Guorui Properties (HKG:2329) Is Weighed Down By Its Debt Load

Sep 02

We Think Shareholders May Want To Consider A Review Of Guorui Properties Limited's (HKG:2329) CEO Compensation Package

Jun 23

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

May 13

Guorui Properties'(HKG:2329) Share Price Is Down 73% Over The Past Five Years.

Jan 31

Should You Use Guorui Properties's (HKG:2329) Statutory Earnings To Analyse It?

Jan 10

What Kind Of Shareholders Hold The Majority In Guorui Properties Limited's (HKG:2329) Shares?

Dec 20

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Dec 03

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 2329 ( CN¥29.7B ) dépassent ses passifs à court terme ( CN¥29.7B ).

Passif à long terme: Les actifs à court terme de 2329 ( CN¥29.7B ) dépassent ses passifs à long terme ( CN¥12.9B ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de 2329 ( 159.7% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de 2329 a été réduit de 161.5% à 160.9% au cours des 5 dernières années.

Couverture de la dette: La dette de 2329 n'est pas bien couverte par le flux de trésorerie opérationnel ( 2.3% ).

Couverture des intérêts: Données insuffisantes pour déterminer si les paiements d'intérêts de 2329 sur sa dette sont bien couverts par l'EBIT.

Glory Health Industry Bilan de santé

Santé financière contrôle des critères 3/6

Informations clés

Mises à jour récentes de la santé financière

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

Health Check: How Prudently Does Glory Health Industry (HKG:2329) Use Debt?

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

We Think Guorui Properties (HKG:2329) Is Taking Some Risk With Its Debt

Here's Why Guorui Properties (HKG:2329) Is Weighed Down By Its Debt Load

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Recent updates

Glory Health Industry Limited to Report First Half, 2024 Results on Aug 30, 2024

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Glory Health Industry Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: CN¥0.13 loss per share (vs CN¥0.20 loss in FY 2022)

Glory Health Industry Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Glory Health Industry Limited Appoints Lam Yuen Ling Eva as Company Secretary

Glory Health Industry Limited Announces the Resignation of Liu Chengjiang as Independent Non-Executive Director, Chairman of the Internal Control Committee and Member of the Audit Committee

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

First half 2023 earnings released: CN¥0.06 loss per share (vs CN¥0.15 loss in 1H 2022)

Glory Health Industry Limited Announces Resignation of Lai Siming as an Independent Non-Executive Director

Glory Health Industry Limited to Report First Half, 2023 Results on Aug 31, 2023

Now 32% undervalued after recent price drop

Glory Health Industry Limited Announces Resignation of Kwong Yin Ping Yvonne as Joint Company Secretary and Authorised Representative, Effective July 1, 2023

Glory Health Industry Limited Announces Retirement of Luo Zhenbang as Independent Non-Executive Director

Glory Health Industry Limited Announces Resignation of Zheng Jin as Joint Company Secretary and an Authorised Representative

Health Check: How Prudently Does Glory Health Industry (HKG:2329) Use Debt?

Glory Health Industry Limited, Annual General Meeting, Jun 30, 2023

Now 21% undervalued after recent price drop

Glory Health Industry Limited Appoints Liu Chengjiang as Independent Non-Executive Director, Chairman of Internal Control Committee and Member of Audit Committee

Now 21% undervalued after recent price drop

A Look At The Fair Value Of Glory Health Industry Limited (HKG:2329)

Full year 2022 earnings released: CN¥0.20 loss per share (vs CN¥0.051 profit in FY 2021)

Glory Health Industry Limited Announces Resignation of Ms. Chen Jingru as Independent Non-Executive Director, Chairman of the Internal Control Committee of the Company and Member of the Audit Committee

Less than half of directors are independent

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

First half 2022 earnings released: CN¥0.15 loss per share (vs CN¥0.06 profit in 1H 2021)

Glory Health Industry Limited Provides Earnings Guidance for Six Months Ended June 30, 2022

Glory Health Industry Limited to Report First Half, 2022 Results on Aug 31, 2022

Less than half of directors are independent

We Think Guorui Properties (HKG:2329) Is Taking Some Risk With Its Debt

Full year 2021 earnings released: EPS: CN¥0.051 (vs CN¥0.022 in FY 2020)

Guorui Properties Limited to Report Fiscal Year 2021 Results on Mar 31, 2022

Less than half of directors are independent

First half 2021 earnings released: EPS CN¥0.06 (vs CN¥0.016 in 1H 2020)

Here's Why Guorui Properties (HKG:2329) Is Weighed Down By Its Debt Load

We Think Shareholders May Want To Consider A Review Of Guorui Properties Limited's (HKG:2329) CEO Compensation Package

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Chairman & President recently bought HK$1.6m worth of stock

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Guorui Properties Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day low: HK$0.73

Guorui Properties'(HKG:2329) Share Price Is Down 73% Over The Past Five Years.

Should You Use Guorui Properties's (HKG:2329) Statutory Earnings To Analyse It?

New 90-day low: HK$0.74

What Kind Of Shareholders Hold The Majority In Guorui Properties Limited's (HKG:2329) Shares?

New 90-day low: HK$0.83

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

New 90-day low: HK$0.84

New 90-day low: HK$0.94

First half earnings released

New 90-day low - HK$1.10

First half earnings released

Guorui Properties Limited to Report First Half, 2020 Results on Aug 31, 2020

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines